{"id":2070,"date":"2004-03-01T12:05:00","date_gmt":"2004-03-01T11:05:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/leserbrief-zur-aussagekraft-der-number-needed-to-treat"},"modified":"2022-03-17T14:10:36","modified_gmt":"2022-03-17T13:10:36","slug":"leserbrief-zur-aussagekraft-der-number-needed-to-treat","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/leserbrief-zur-aussagekraft-der-number-needed-to-treat","title":{"rendered":"Leserbrief: Zur Aussagekraft der Number needed to treat"},"content":{"rendered":"<p>Prof. Dr. J. Windeler, Essen, schreibt zu unserer Leserbrief-Beantwortung (AMB 2003, 37, 63): >> David Sackett handelte zweifellos in bester Absicht und aus fundierter praxisorientierter \u00dcberlegung heraus, als er das Konzept der Number Needed to Treat (NNT) als Reziprok der absoluten Risikodifferenz vorschlug. Es stellt sich jedoch die Frage, ob er diesen Vorschlag auch gemacht [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Prof. Dr. J. Windeler, Essen, schreibt zu unserer Leserbrief-Beantwortung (AMB 2003, 37, 63): >> David Sackett handelte zweifellos in bester Absicht und aus fundierter praxisorientierter \u00dcberlegung heraus, als er das Konzept der Number Needed to Treat (NNT) als Reziprok der absoluten Risikodifferenz vorschlug. Es stellt sich jedoch die Frage, ob er diesen Vorschlag auch gemacht [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2523,4248,1409],"class_list":["post-2070","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-number-needed-to-treat","tag-statistik","tag-studien"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2070"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2070\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}